Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AVernon, Tarasov KV, Müller M, Sotoodehnia N, Sinner MF, et al. Genome-wide association study of PR interval. Nat Genet. 2010  ;42(2):153-9.

Newman AB, Walter S, Lunetta KL, Garcia ME, P Slagboom E, Christensen K, Arnold AM, Aspelund T, Aulchenko YS, Benjamin EJ, et al. A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium. J Gerontol A Biol Sci Med Sci. 2010  ;65(5):478-87.

Marciante KD, Durda JP, Heckbert SR, Lumley T, Rice K, McKnight B, Totah RA, Tamraz B, Kroetz DL, Fukushima H, et al. Cerivastatin, genetic variants, and the risk of rhabdomyolysis. Pharmacogenet Genomics. 2011  ;21(5):280-8.

Wilk JB, Shrine NRG, Loehr LR, Zhao JH, Manichaikul A, Lopez LM, Smith AVernon, Heckbert SR, Smolonska J, Tang W, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med. 2012  ;186(7):622-32.